Stock screener

ALGS

Conviction 0HealthcareScan · Fri, Jun 26, 2026
ALGS$5.55+0.91%
ResistanceSupportVol 14
63 bars
Vol MA14 64.31K
Mar 27Apr 15May 4May 20Jun 9Jun 26
Aligos Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.aligos.com
Price5.55
Change+0.91%
Gap+4.27%
Rel volume0.10×
Avg volume86.22K
Avg $ vol457.65K
SMA 205.31
SMA 505.83
SMA 2007.93
Price vs 50-4.82%
Price vs 200-30.03%
MA stackbearish
50/200 cross
Supertrenddown · 6.16
RSI (14)50
MACD hist0.09
MACD cross
Stoch %K / %D62 / 64
ADX (14)16
+DI / −DI23 / 19
RSI divergence
MACD divergence
ATR %+7.41%
ADR %7.15%
52w high13.30
52w low4.91
From 52w high-58.25%
Above 52w low+13.03%
New 52w highNo
SqueezeOn · 10d
Bollinger width17.60%
%B0.76
Donchian pos65.79%
Donchian high5.94
Donchian low4.80
AVWAP (52w high)7.31
vs AVWAP high-24.03%
AVWAP (52w low)5.29
vs AVWAP low+4.82%
OBV trendDown
Chaikin MF (20)-0.25
Today vs 20d0.10×
Avg vol (14d)64.31K
Avg vol (20d)86.22K
Avg $ vol (20d)457.65K
Market cap
RS 3m (vs SPY)-32.77%
RS 6m (vs SPY)-56.06%
RS line new highNo
Trend template0/8
Technical rank16.8
1 week+5.11%
1 month-0.89%
3 months-21.16%
6 months-44.22%
1 year-27.26%
YTD-39.21%
P/E-9.70
P/B7.39
P/S107.40
P/FCF-2.84
EPS-2.45
Div yield
ROE-76.10%
ROA-37.47%
Debt/Eq
Current2.56
EV/EBITDA
Gross margin
Net margin
Rev growth-39.46%
EPS growth81.56%
Price target
Target upside
Analyst rating
Institutional
Ent. value204.79M
Revenue2.83M
Net income-23.04M
Gross profit
Free cash flow-82.63M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out5.39M
Employees82
ListedFri, Oct 16, 2020
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction0 / 100
Pattern quality
Tech rank16.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance6.82
Support4.86
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALGS

All disclosures →
No recent disclosed trades by Congress in ALGS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ALGS

No recent insider (Form 4) filings in ALGS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ALGS · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.